Nano Dimension (NNDM) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 Aug, 2026Executive summary
Revenue for the six months ended June 30, 2026, increased 46% year-over-year to $58.7 million, driven by the inclusion of Markforged and higher SMT product line sales.
Q2 2026 revenue was $29.0 million, up 12.1% year-over-year, with strong Essemtec performance and record results in electronics, AI, and aerospace.
Net loss from continuing operations was $76.5 million for the six months, primarily due to a $40.4 million goodwill impairment related to Markforged; Q2 net loss narrowed to $6.8 million.
Significant acquisitions (Markforged, Desktop Metal) and divestitures (AME and Fabrica product lines) were completed.
As of June 30, 2026, cash, cash equivalents, bank deposits, and marketable securities totaled $433.3 million.
Financial highlights
Product revenue rose 48% year-over-year to $46.9 million; service revenue increased 39% to $11.8 million.
Gross profit nearly doubled to $25.4 million for the six months; Q2 GAAP gross profit was $13.3 million, up 88.8% year-over-year.
Operating expenses included $40.4 million goodwill impairment and $9.9 million restructuring costs.
Adjusted EBITDA loss from continuing operations was $22.1 million for the six months and $9.6 million for Q2 2026.
Net cash used in operating activities was $31.0 million; investing activities provided $170.5 million, mainly from deposit maturities.
Outlook and guidance
Management expects continued operating losses in the near term as investments in R&D and sales/marketing persist.
Full-year 2026 financial guidance has been suspended due to ongoing strategic actions and potential further changes.
Current liquidity is expected to be sufficient for at least the next 12 months and into 2027.
The sale of Markforged to Stratasys for $42.5 million is expected to close in the second half of 2026, pending regulatory approvals.
Focus areas include cost structure reduction, monetizing non-core assets, and driving toward positive cash flow.
Latest events from Nano Dimension
- Shareholders face a pivotal vote on Board control, with future input on strategic transactions.NNDM
Proxy filing - Proxy contest seeks board overhaul, annual elections, and more shareholder control over key decisions.NNDM
Proxy filing - Shareholders will vote on strategic direction, governance amendments, and board composition changes.NNDM
Proxy filing - Board supports strategic review and declassification, opposes governance and director changes.NNDM
Proxy filing - Proxy contest aims to declassify the board, restrict poison pills, and replace key directors.NNDM
Proxy filing - Proposed merger with Infinite Epigenetics offers a 20% premium and pivots to AI-powered diagnostics.NNDM
Proxy filing - $890M merger forms a Nasdaq-listed AI diagnostics leader targeting the $90–94B U.S. market.NNDM
M&A announcement - Q3 revenue surged 81% to $26.9M, but margins fell; Q4 guidance: $31.5M–$33.5M.NNDM
Q3 2025 - Record Q2 revenue, improved margins, and a transformative acquisition highlight best quarter.NNDM
Q2 2024